Table 1 Clinical and laboratory data in patients with T1D (Germany and Austria) and T2D (Germany); the numbers refer to the most recent year of treatment

Total number of patients

30,998

2,025

1,252

Current age (yrs)

30,998

17.5 (16.2–18.5)

2,025

17.8 (16.8–19.0)

1,252

17.4 (16.0–19.6)

Diabetes duration (yrs)

30,998

7.3 (3.9–11.2)

2,025

8.3 (4.7–12.1)

1,252

1.4 (0.2–3.1)

Sex (% male)

30,998

54.5

2,025

56.1

1,252

43.2

Migration background (((%)

30,998

22.7

2,025

28.7

1,252

33.0

Current BMI SDS^a

27,940

0.6 (−0.1–1.3)

1,787

0.6 (−0.1–1.3)

1,108

2.6 (2.1–3.1)

Current A1c (%)

29,787

7.8 (7.0–8.8)

1,962

7.7 (6.9–8.7)

971

6.5 (5.6–8.1)

Current A1c (mmol/mol)

29,787

61.2 (52.6–73.1)

1,962

60.4 (52.2–72.0)

971

47.2 (37.9–64.8)

% of smokers

30,998

13.1

2,025

15.9

1,252

16.9

% of patients physically activity (≥ once/week)

24,322

64.6

1,525

74.1

879

49.7

% with elevated blood pressure

30,544

10.7

1,797

12.1

1,220

27.8

% with dyslipidemia

23,116

28.4

1,574

19.2

859

63.7

% with insulin therapy

30,998

100

2,025

100

1,252

38.0

% with insulin pump therapy

30,998

49.4

2,025

55.1

1,252

1.2

% with CGMS

30,998

73.3

2,025

77.0

1,252

22.0

% with sensor-augmented pump therapy

30,998

39.6

2,025

44.0

1,252

0.6

% with hybrid closed loop system

30,998

15.2

2,025

15.4

1,252

0.4